References
- Rezaei N, Moazzami K, Aghamohammadi A, Klein C. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28(5):335–366. doi:https://doi.org/10.1080/08830180902995645.
- Spoor J, Farajifard H, Rezaei N. Congenital neutropenia and primary immunodeficiency diseases. Crit Rev Oncol Hematol. 2019;133:149–162. doi:https://doi.org/10.1016/j.critrevonc.2018.10.003.
- Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24–64. doi:https://doi.org/10.1007/s10875-019-00737-x.
- Yazdani R, Abolhassani H, Asgardoon M, et al. Infectious and Noninfectious Pulmonary Complications in Patients With Primary Immunodeficiency Disorders. J Investig Allergol Clin Immunol. 2017;27(4):213–224. doi:https://doi.org/10.18176/jiaci.0166.
- Azizi G, Abolhassani H, Asgardoon MH, et al. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord Drug Targets. 2016;16(2):80–88. doi:https://doi.org/10.2174/1871530316666160724214418.
- Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies. J Allergy Clin Immunol Pract. 2016;4(6):1089–1100. doi:https://doi.org/10.1016/j.jaip.2016.08.004.
- Izak M, Bussel JB. Management of thrombocytopenia. F1000Prime Rep. 2014;6 doi:https://doi.org/10.12703/P6-45.
- Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):495–520. doi:https://doi.org/10.1016/j.hoc.2013.03.001.
- Grodzicky T, Bussel J, Elkon K. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients . Clin Exp Immunol. 2002;127(2):289–292. doi:https://doi.org/10.1046/j.1365-2249.2002.01750.x.
- Smock K, Perkins S. Thrombocytopenia: an update. Int J Lab Hematol. 2014;36(3):269–278. doi:https://doi.org/10.1111/ijlh.12214.
- Moake J. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Best Pract Res Clin Haematol. 2009;22(4):567–576. doi:https://doi.org/10.1016/j.beha.2009.07.004.
- Park H-K, Lee S-H. Ischemic stroke associated with immune thrombocytopenia: lesion patterns and characteristics. Neurol Sci. 2014;35(11):1801–1806. doi:https://doi.org/10.1007/s10072-014-1843-0.
- Human A, Murguia-Favela L, Benson L, Roifman I, Grunebaum E. Cardiovascular abnormalities in primary immunodeficiency diseases. LymphoSign J. 2015;2(3):107–134. doi:https://doi.org/10.14785/lpsn-2014-0013.
- Epaulard O, Foote A, Bosson J-L, editors. Chronic infection and venous thromboembolic disease. Seminars Thrombosis Hemostasis. 2015. Thieme Medical Publishers. doi:https://doi.org/10.1055/s-0035-1556729.
- Rondina MT, Guo L. The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol. 2019;10:2204 doi:https://doi.org/10.3389/fimmu.2019.02204.
- Amaya-Uribe L, Rojas M, Azizi G, Anaya J-M, Gershwin ME. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52–72. doi:https://doi.org/10.1016/j.jaut.2019.01.011.
- Haas OA. Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework. Front Immunol. 2018;9:3136 doi:https://doi.org/10.3389/fimmu.2018.03136.
- Liebman HA. Thrombocytopenia in cancer patients. Thrombosis Res. 2014;133:S63–S9. doi:https://doi.org/10.1016/S0049-3848(14)50011-4.
- Sarpatwari A, Bennett D, Logie JW, et al. Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database. haematologica. 2010;95(7):1167–1175. doi:https://doi.org/10.3324/haematol.2009.018390.
- Swinkels M, Rijkers M, Voorberg J, Vidarsson G, Leebeek FW, Jansen A. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880 doi:https://doi.org/10.3389/fimmu.2018.00880.
- AlKhater S. CNS vasculitis and stroke as a complication of DOCK8 deficiency: a case report. BMC Neurol. 2016;16(1):54 doi:https://doi.org/10.1186/s12883-016-0578-3.
- Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood J Am Soc Hematol. 2009;113(26):6511–6521. doi:https://doi.org/10.1182/blood-2009-01-129155.
- Standing A. Thrombocytopaenia: A Defect in Actin Dynamics? 2017.
- Swan DJ, Aschenbrenner D, Lamb CA, et al. Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ. haematologica. 2019;104(10):e483–e486. doi:https://doi.org/10.3324/haematol.2018.208397.
- Chen M, Yan R, Zhou K, et al. Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia. Proc Natl Acad Sci U S A. 2018;115(45):E10682–E91. doi:https://doi.org/10.1073/pnas.1808217115.
- Lam FW, Vijayan KV, Rumbaut RE. Platelets and their interactions with other immune cells. Comprehensive Physiol. 2011;5(3):1265–1280.
- Li C, Li J, Li Y, et al. Crosstalk between platelets and the immune system: old systems with new discoveries. Adv Hematol. 2012;2012:384685. doi:https://doi.org/10.1155/2012/384685.
- Tichelaar YV, Kluin-Nelemans HJ, Meijer K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic reviewThromb Haemost. 2012;107(5):827–837. doi:https://doi.org/10.1160/TH11-09-0611.
- Bluestone J, Khattri R, Sciammas R, Sperling A. TCR gamma delta cells: a specialized T-cell subset in the immune system . Annu Rev Cell Dev Biol. 1995;11(1):307–353. doi:https://doi.org/10.1146/annurev.cb.11.110195.001515.
- Ji X, Zhang L, Peng J, Hou M. T cell immune abnormalities in immune thrombocytopenia. J Hematol Oncol. 2014;7(1):72 doi:https://doi.org/10.1186/s13045-014-0072-6.
- Alsalamah M, Sarpal A, Siu VM, et al. Hemophagocytic lymphohistiocytosis in a patient with CD3δ deficiency. LymphoSign J. 2015;2(4):201–206. doi:https://doi.org/10.14785/lpsn-2015-0006.
- Hoenig M, Lagresle-Peyrou C, Pannicke U, et al. Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome. Blood J Am Soc Hematol. 2017;129(21):2928–2938. doi:https://doi.org/10.1182/blood-2016-11-745638.
- Staines Boone AT, Chinn IK, Alaez-Versón C, et al. Failing to Make Ends Meet: The Broad Clinical Spectrum of DNA Ligase IV Deficiency. Case Series and Review of the Literature. Front Pediatr. 2018;6:426 doi:https://doi.org/10.3389/fped.2018.00426.
- Yazdani R, Abolhassani H, Tafaroji J, et al. Cernunnos deficiency associated with BCG adenitis and autoimmunity: first case from the national Iranian registry and review of the literature. Clin Immunol. 2017;183:201–206. doi:https://doi.org/10.1016/j.clim.2017.07.007.
- Lawless D, Geier CB, Farmer JR, NIHR BioResource–Rare Diseases Consortium, et al. Prevalence and clinical challenges among adults with primary immunodeficiency and recombination-activating gene deficiency. J Allergy Clin Immunol. 2018;141(6):2303–2306. doi:https://doi.org/10.1016/j.jaci.2018.02.007.
- Halacli SO, Ayvaz DC, Sun-Tan C, et al. STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: A novel mutation. Clin Immunol. 2015;161(2):316–323. doi:https://doi.org/10.1016/j.clim.2015.06.010.
- Alizadeh Z, Mazinani M, Shakerian L, Nabavi M, Fazlollahi MR. DOCK2 deficiency in a patient with hyper IgM phenotype. J Clin Immunol. 2018;38(1):10–12. doi:https://doi.org/10.1007/s10875-017-0468-5.
- Gallego-Bustos F, Gotea V, Ramos-Amador JT, et al. A case of IL-7R deficiency caused by a novel synonymous mutation and implications for mutation screening in SCID diagnosis. Front Immunol. 2016;7:443 doi:https://doi.org/10.3389/fimmu.2016.00443.
- Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38(5):569–578. doi:https://doi.org/10.1007/s10875-018-0525-8.
- Shabanova I, Cohen E, Cada M, Vincent A, Cohn RD, Dror Y. ERCC6L2-associated inherited bone marrow failure syndrome . Mol Genet Genomic Med. 2018;6(3):463–468. doi:https://doi.org/10.1002/mgg3.388.
- Ashby G, Evans D. Cartilage hair hypoplasia with thrombocytopenic purpura, autoimmune haemolytic anaemia and cell-mediated immunodeficiency. J R Soc Med. 1986;79(2):113–114. doi:https://doi.org/10.1177/014107688607900216.
- Jaeken J, Lefeber DJ, Matthijs G. Clinical Utility Gene Card for: PGM3 defective congenital disorder of glycosylation. Eur J Hum Genet. 2019;27(11):1757–1760. doi:https://doi.org/10.1038/s41431-019-0453-y.
- Picard C, McCarl C-A, Papolos A, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med. 2009;360(19):1971–1980. doi:https://doi.org/10.1056/NEJMoa0900082.
- Sara I, Ali Saeedi B, Arash A, Abolnezhadian F. Ataxia Telangiectasia Presenting with Idiopathic Thrombocytopenic Purpura in a 4-Year-Old Boy. J Hematol Thrombo Dis. 2018;6(294):2.
- Bakr A, Eid R, Sarhan A, et al. Schimke immune-osseous dysplasia: A case report. Saudi J Kidney Dis Transpl. 2015;26(5):987–991. doi:https://doi.org/10.4103/1319-2442.164585.
- Heremans J, Garcia-Perez JE, Turro E, National Institute for Health Research BioResource, et al. Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome. J Allergy Clin Immunol. 2018;142(2):630–646. doi:https://doi.org/10.1016/j.jaci.2017.11.061.
- La Marca G, Canessa C, Giocaliere E, et al. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots. J Allergy Clin Immunol. 2014;134(1):155–159. e3. doi:https://doi.org/10.1016/j.jaci.2014.01.040.
- Pugliese-Pires PN, Tonelli CA, Dora JM, et al. A novel STAT5B mutation causing GH insensitivity syndrome associated with hyperprolactinemia and immune dysfunction in two male siblings. Eur J Endocrinol. 2010;163(2):349–355. doi:https://doi.org/10.1530/EJE-10-0272.
- Bradshaw G, Lualhati RR, Albury CL, Maksemous N, et al. Exome sequencing diagnoses x-linked moesin-associated immunodeficiency in a primary immunodeficiency case. Front Immunol. 2018;9:420 doi:https://doi.org/10.3389/fimmu.2018.00420.
- Tan J, Li X, Guo Y, et al. Hereditary folate malabsorption with a novel mutation on SLC46A1: A case report. Medicine (Baltimore). 2017;96(50):e8712. doi:https://doi.org/10.1097/MD.0000000000008712.
- Al-Mousa H, Hawwari A, Al-Ghonaium A, et al. Hematopoietic stem cell transplantation corrects WIP deficiency. J Allergy Clin Immunol. 2017;139(3):1039–1040. e4. doi:https://doi.org/10.1016/j.jaci.2016.08.036.
- Ramphul K, Ramjuttun S, Poorun V. Wiskott-Aldrich Syndrome (WAS): A Case Report in Mauritius and Review. Int J Pediatrics. 2015;3(3.1):579–583.
- Quinn P, Pearson C, Cheung A, et al. P84: combined immunodeficiency due to deficiency of actinrelated protein complex 1B (ARPC1B). Intern Med J. 2017;47:29–30. doi:https://doi.org/10.1111/imj.84_13578.
- Rosa RFM, Rosa RCM, Dos Santos PPA, Zen PRG, Paskulin GA. Hematological abnormalities and 22q11.2 deletion syndrome. Rev Bras Hematol Hemoter. 2011;33(2):151–154. doi:https://doi.org/10.5581/1516-8484.20110037.
- Nahum A, Manson D, Ngan B. Atypical presentation and manifestations in X-linked agammaglobulinemia patients with novel BTK mutations. LymphoSign Journal. 2015;2(2):75–83. doi:https://doi.org/10.14785/lpsn-2014-0015.
- Boztug H, Hirschmugl T, Holter W, et al. NF-κB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation. J Clin Immunol. 2016;36(6):533–540. doi:https://doi.org/10.1007/s10875-016-0306-1.
- Hartman HN, Niemela J, Hintermeyer MK, et al. Gain of function mutations of PIK3CD as a cause of primary sclerosing cholangitis. J Clin Immunol. 2015;35(1):11–14. doi:https://doi.org/10.1007/s10875-014-0109-1.
- Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. 2020;:1–16.
- Van Zelm MC, Smet J, Adams B, et al. CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. J Clin Invest. 2010;120(4):1265–1274. doi:https://doi.org/10.1172/JCI39748.
- Zhang L, Radigan L, Salzer U, et al. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol. 2007;120(5):1178–1185. doi:https://doi.org/10.1016/j.jaci.2007.10.001.
- Hansen OP, SØrensen CH, Astrup L. Evans' Syndrome in IgA Deficiency Episodic Autoimmune Haemolytic Anaemia and Thrombocytopenia during a 10 Years Observation Period. Scand J Haematol. 1982;29(3):265–270. doi:https://doi.org/10.1111/j.1600-0609.1982.tb00592.x.
- Terada T, Kaneko H, Li AL, et al. Analysis of Ig subclass deficiency: First reported case of IgG2, IgG4, and IgA deficiency caused by deletion of C alpha 1, psi C gamma, C gamma 2, C gamma 4, and C epsilon in a Mongoloid patient. J Allergy Clin Immunol. 2001;108(4):602–606. doi:https://doi.org/10.1067/mai.2001.118293.
- Kanegane H, Agematsu K, Futatani T, et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 2007;8(8):663–670. doi:https://doi.org/10.1038/sj.gene.6364431.
- Sriaroon P, Chang Y, Ujhazi B, et al. Familial immune thrombocytopenia associated with a novel variant in IKZF1. Front Pediatr. 2019;7(139)
- Lev A, Simon AJ, Barel O, et al. Reduced function and diversity of T cell repertoire and distinct clinical course in patients with IL7RA mutation. Front Immunol. 2019;10:1672 doi:https://doi.org/10.3389/fimmu.2019.01672.
- Garcillán B, Marin AV, Jiménez-Reinoso A, et al. γδ T Lymphocytes in the Diagnosis of Human T Cell Receptor Immunodeficiencies. Front Immunol. 2015;6:20 doi:https://doi.org/10.3389/fimmu.2015.00020.
- Ghaloul-Gonzalez L, Mohsen A-W, Karunanidhi A, et al. Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation. Sci Rep. 2019;9(1):1–8. doi:https://doi.org/10.1038/s41598-019-51922-2.
- Pannicke U, Hönig M, Hess I, et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nat Genet. 2009;41(1):101–105. doi:https://doi.org/10.1038/ng.265.
- Notarangelo LD, Kim M-S, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol. 2016;16(4):234–246. doi:https://doi.org/10.1038/nri.2016.28.
- Kim J-I, Park J-S, Kim H, et al. CRISPR/Cas9-mediated knockout of Rag-2 causes systemic lymphopenia with hypoplastic lymphoid organs in FVB mice. Lab Anim Res. 2018;34(4):166–175. doi:https://doi.org/10.5625/lar.2018.34.4.166.
- Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11(1):159 doi:https://doi.org/10.1186/s13023-016-0543-7.
- Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997;15(1):177–202. doi:https://doi.org/10.1146/annurev.immunol.15.1.177.
- Amirifar P, Yazdani R, Moeini Shad T, et al. Cutaneous granulomatosis and class switching defect as a presenting sign in ataxia-telangiectasia: first case from the national Iranian registry and review of the literature. Immunol Invest. 2020;49(6):597–610. doi:https://doi.org/10.1080/08820139.2019.1692864.
- Lev A, Amariglio N, Levy Y, et al. Molecular assessment of thymic capacities in patients with Schimke immuno-osseous dysplasia. Clin Immunol. 2009;133(3):375–381. doi:https://doi.org/10.1016/j.clim.2009.08.017.
- Clewing JM, Antalfy BC, Lücke T, et al. Schimke immuno-osseous dysplasia: a clinicopathological correlation. J Med Genet. 2007;44(2):122–130. doi:https://doi.org/10.1136/jmg.2006.044313.
- Grenda R, Jarmużek W, Latoszyńska J, Prokurat S, Rubik J. Eltrombopag (thrombopoietin-receptor agonist) and plasmapheresis as rescue therapy of acute post-renal transplant immune thrombocytopenia in a child with Schimke immuno-osseous dysplasia-case report . Pediatr Transplant. 2016;20(8):1148–1151. doi:https://doi.org/10.1111/petr.12828.
- Krøigård AB, Frost M, Larsen MJ, Ousager LB, Frederiksen AL. Bone structure in two adult subjects with impaired minor spliceosome function resulting from RNU4ATAC mutations causing microcephalic osteodysplastic primordial dwarfism type 1 (MOPD1). Bone. 2016;92:145–149. doi:https://doi.org/10.1016/j.bone.2016.08.023.
- Takenouchi T, Kosaki R, Niizuma T, Hata K, Kosaki K. Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delay. Am J Med Genet. 2015;167(11):2822–2825. doi:https://doi.org/10.1002/ajmg.a.37275.
- Dütting S, Gaits-Iacovoni F, Stegner D, et al. A Cdc42/RhoA Regulatory Circuit Downstream of Glycoprotein Ib Guides Transendothelial Platelet Biogenesis. Nat Commun. 2017;8(1):1–13.
- Pleines I, Dütting S, Cherpokova D, et al. Defective tubulin organization and proplatelet formation in murine megakaryocytes lacking Rac1 and Cdc42. Blood. 2013;122(18):3178–3187. doi:https://doi.org/10.1182/blood-2013-03-487942.
- Tsui M, Biro J, Chan J, Min W, Grunebaum E. Use of induced pluripotent stem cells to investigate the effects of purine nucleoside phosphorylase deficiency on neuronal development. LymphoSign Journal. 2018;5(2):49–56. doi:https://doi.org/10.14785/lymphosign-2018-0003.
- Dror Y, Grunebaum E, Hitzler J, et al. Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology. Pediatr Res. 2004;55(3):472–477. doi:https://doi.org/10.1203/01.PDR.0000111286.23110.F8.
- Olson TA, Levine RF, Kelleher J. Familial thrombocytopenia with micromegakaryocytes. Am J Pediatr Hematol Oncol. 1992;14(3):248–254.
- Muhury M, Mathai AM, Rai S, Naik R, Pai MR, Sinha R. Megakaryocytic alterations in thrombocytopenia: A bone marrow aspiration study. Indian J Pathol Microbiol. 2009;52(4):490–494. doi:https://doi.org/10.4103/0377-4929.56132.
- Bitar M, Boldt A, Freitag M-T, Gruhn B, Köhl U, Sack U. Evaluating STAT5 phosphorylation as a mean to assess T cell proliferation. Front Immunol. 2019;10:722 doi:https://doi.org/10.3389/fimmu.2019.00722.
- Majri SS, Fritz JM, Villarino AV, et al. STAT5B: a differential regulator of the life and death of CD4+ effector memory T cells. J Immunol. 2018;200(1):110–118. doi:https://doi.org/10.4049/jimmunol.1701133.
- Schulze H, Ballmaier M, Welte K, Germeshausen M. Thrombopoietin induces the generation of distinct Stat1, Stat3, Stat5a and Stat5b homo-and heterodimeric complexes with different kinetics in human platelets. Exp Hematol. 2000;28(3):294–304. doi:https://doi.org/10.1016/S0301-472X(99)00154-X.
- Park HJ, Li J, Hannah R, et al. Cytokine-induced megakaryocytic differentiation is regulated by genome-wide loss of a uSTAT transcriptional program . Embo J. 2016;35(6):580–594. doi:https://doi.org/10.15252/embj.201592383.
- Wang Z, Bunting KD. STAT5 in hematopoietic stem cell biology and transplantation. JAKSTAT. 2013;2(4):e27159 doi:https://doi.org/10.4161/jkst.27159.
- Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117(2):407–418. doi:https://doi.org/10.1172/JCI29539.
- Moulding DA, Record J, Malinova D, Thrasher AJ. Actin cytoskeletal defects in immunodeficiency. Immunol Rev. 2013;256(1):282–299. doi:https://doi.org/10.1111/imr.12114.
- Fischer A. Platelets are the Achilles' heel of Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2019;144(3):668–670. doi:https://doi.org/10.1016/j.jaci.2019.06.039.
- Haddad E, Cramer E, Rivière C, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood J Am Soc Hematol. 1999;94(2):509–518.
- Massaad MJ, Ramesh N, Le Bras S, et al. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding. J Allergy Clin Immunol. 2011;127(4):998–1005. e2. doi:https://doi.org/10.1016/j.jaci.2011.01.015.
- Antón IM, de la Fuente MA, Sims TN, et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity. 2002;16(2):193–204. doi:https://doi.org/10.1016/S1074-7613(02)00268-6.
- Quach ME, Chen W, Li R. Mechanisms of platelet clearance and translation to improve platelet storage. Blood. 2018;131(14):1512–1521. doi:https://doi.org/10.1182/blood-2017-08-743229.
- Cranmer SL, Ashworth KJ, Yao Y, et al. High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction. Blood J Am Soc Hematol. 2011;117(9):2718–2727. doi:https://doi.org/10.1182/blood-2010-07-296194.
- Brigida I, Zoccolillo M, Cicalese MP, et al. T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency. Blood J Am Soc Hematol. 2018;132(22):2362–2374. doi:https://doi.org/10.1182/blood-2018-07-863431.
- Kahr WH, Pluthero FG, Elkadri A, et al. Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat Commun. 2017;8(1):14816–14814. doi:https://doi.org/10.1038/ncomms14816.
- Vergés L, Vidal F, Geán E, Alemany-Schmidt A, Oliver-Bonet M, Blanco J. An exploratory study of predisposing genetic factors for DiGeorge/velocardiofacial syndrome. Sci Rep. 2017;7(1):40031–40011. doi:https://doi.org/10.1038/srep40031.
- Shetty M, Srikanth A, Kadandale J, Hegde S. Pre- and Postnatal Diagnosis of 10p14 Deletion and 22q11.2 Deletion Syndrome and Significance of Non-Cardiac Markers . Cytogenet Genome Res. 2016;148(4):249–255. doi:https://doi.org/10.1159/000446162.
- Kato T, Kosaka K, Kimura M, et al. Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ib-beta. Genet Med. 2003;5(2):113–119. doi:https://doi.org/10.1097/01.GIM.0000056828.03164.30.
- Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan K. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr. 2003;143(2):277–278. doi:https://doi.org/10.1067/S0022-3476(03)00248-8.
- Smith T, Cunningham-Rundles C. Primary B-cell immunodeficiencies. Hum Immunol. 2019;80(6):351–362. doi:https://doi.org/10.1016/j.humimm.2018.10.015.
- Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females . Br J Haematol. 2001;114(1):141–149. doi:https://doi.org/10.1046/j.1365-2141.2001.02905.x.
- Singh SP, Dammeijer F, Hendriks RW. Role of Bruton's tyrosine kinase in B cells and malignancies. Mol Cancer. 2018;17(1):57 doi:https://doi.org/10.1186/s12943-018-0779-z.
- Klemann C, Camacho-Ordonez N, Yang L, et al. Clinical and immunological phenotype of patients with primary immunodeficiency due to damaging mutations in NFKB2. Front Immunol. 2019;10:297 doi:https://doi.org/10.3389/fimmu.2019.00297.
- Lee CE, Fulcher DA, Whittle B, et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood. 2014;124(19):2964–2972. doi:https://doi.org/10.1182/blood-2014-06-578542.
- Mussbacher M, Salzmann M, Brostjan C, et al. Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol. 2019;10:85. doi:https://doi.org/10.3389/fimmu.2019.00085.
- Zhang Y, Sun S, Wang Z, et al. Signaling by the Mpl receptor involves IKK and NF-kappaB. J Cell Biochem. 2002;85(3):523–535. doi:https://doi.org/10.1002/jcb.10141.
- Padovani JL, Corvino SM, Drexler JF, Silva GF, Pardini M, Grotto RMT. In vitro detection of hepatitis C virus in platelets from uninfected individuals exposed to the virus. Rev Soc Bras Med Trop. 2013;46(2):154–155. doi:https://doi.org/10.1590/0037-8682-1627-2013.
- Luo RF, Zhao S, Tibshirani R, et al. CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Hum Pathol. 2010;41(2):271–280. doi:https://doi.org/10.1016/j.humpath.2009.07.022.
- Van Zelm MC, Reisli I, Van Der Burg M, Castaño D, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354(18):1901–1912. doi:https://doi.org/10.1056/NEJMoa051568.
- Asnafi AA, Moghtadaei M, Behzad MM, Saki N. Is there correlation between CD19, CD20, and CD25 expressions with platelet changes within 6 months in children with immune thrombocytopenic purpura? Clin Cancer Investig J. 2019;8(1):7. doi:https://doi.org/10.4103/ccij.ccij_105_18.
- Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008;8(6):520–526. doi:https://doi.org/10.1097/ACI.0b013e3283141200.
- Castigli E, Wilson SA, Garibyan L, et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet. 2005;37(8):829–834. doi:https://doi.org/10.1038/ng1601.
- Gu D, Ge J, Du W, et al. Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications. Autoimmunity. 2009;42(8):692–698. doi:https://doi.org/10.3109/08916930903214025.
- Chen Q, Shi Y, Chen Y, Ji T, Li Y, Yu LJG. Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases. Gene. 2019;684:47–52. doi:https://doi.org/10.1016/j.gene.2018.10.045.
- Kuehn HS, Niemela JE, Stoddard J, et al. Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies. Blood. 2020; doi:https://doi.org/10.1182/blood.2020007292.
- Eskandarian Z, Fliegauf M, Bulashevska A, et al. Assessing the functional relevance of variants in the IKAROS family zinc finger protein 1 (IKZF1) in a cohort of patients with primary immunodeficiency. Front Immunol. 2019;10:568. doi:https://doi.org/10.3389/fimmu.2019.00568.
- Malinge S, Thiollier C, Chlon TM, et al. Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling. Blood J Am Soc Hematol. 2013;121(13):2440–2451. doi:https://doi.org/10.1182/blood-2012-08-450627.
- Vannucchi AM. Pegasus causes inherited thrombocytopenia. Blood. 2019;134(23):2000–2002. doi:https://doi.org/10.1182/blood.2019002181.
- Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30(1):10–16. doi:https://doi.org/10.1007/s10875-009-9357-x.
- Aghamohammadi A, Cheraghi T, Gharagozlou M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009;29(1):130–136. doi:https://doi.org/10.1007/s10875-008-9229-9.
- Plebani A, Monafo V, Avanzini M, Ugazio A, Burgio G. Relationship between IgA and IgG subclass deficiencies: a reappraisal. Monogr Allergy. 1986;20:171–178.
- Chong C, Lee T, Ho M, Lee S, Lau Y. Immunology & Infectious Diseases Forum Review of IgG Subclass and IgA Deficiency in a Tertiary Center 一個教學醫院治療 IgG 亞群及 IgA 缺乏患者的經驗. HK J Paediatr (New Series). 2006;11(3):205–209.
- Esteban MÁ, Cuesta A, Chaves-Pozo E, Meseguer J. Phagocytosis in teleosts. Implications of the new cells involved. Biology (Basel). 2015;4(4):907–922. doi:https://doi.org/10.3390/biology4040907.
- Rosales C, Demaurex N, Lowell CA, Uribe-Querol E. Neutrophils: their role in innate and adaptive immunity. J Immunol Res. 2016;2016:1469780. doi:https://doi.org/10.1155/2016/1469780.
- Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118(9):1392–1408. doi:https://doi.org/10.1161/CIRCRESAHA.116.306853.
- Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res. 2013;131(3):191–197. doi:https://doi.org/10.1016/j.thromres.2012.11.028.
- Kral JB, Schrottmaier WC, Salzmann M, Assinger A. Platelet interaction with innate immune cells. Transfus Med Hemother. 2016;43(2):78–88. doi:https://doi.org/10.1159/000444807.
- Nunoi H, Yamazaki T, Tsuchiya H, et al. A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection . Proc Natl Acad Sci U S A. 1999;96(15):8693–8698. doi:https://doi.org/10.1073/pnas.96.15.8693.
- Standing AS, Malinova D, Hong Y, et al. Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1. J Exp Med. 2017;214(1):59–71. doi:https://doi.org/10.1084/jem.20161228.
- Kiykim A, Baris S, Karakoc-Aydiner E, et al. G6PC3 deficiency: primary immune deficiency beyond just neutropenia. J Pediatr Hematol Oncol. 2015;37(8):616–622. doi:https://doi.org/10.1097/MPH.0000000000000441.
- Pierre G, Chakupurakal G, Mckiernan P, Hendriksz C, Lawson S, Chakrapani A. Bone marrow transplantation in glycogen storage disease type 1b. J Pediatr. 2008;152(2):286–288. doi:https://doi.org/10.1016/j.jpeds.2007.09.031.
- Scaramucci L, Niscola P, Palombi M, Tendas A, Giovannini M, de Fabritiis P. Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency/Glukoz-6-Fosfat Dehidrogenaz Eksikligi Tasiyicisinda Eltrombopag Yanitli Immün Trombositopeni. Turk J Haematol. 2016;33(1):77–78. doi:https://doi.org/10.4274/tjh.2015.0181.
- Sarkar S, Mondal R, Nandi M. Chronic granulomatous disease presenting as immune thrombocytopenic purpura. Sri Lanka J Child Health. 2014;43(3):177. doi:https://doi.org/10.4038/sljch.v43i3.7383.
- Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010;116(23):4990–5001. doi:https://doi.org/10.1182/blood-2010-05-286534.
- Pollack SM, Gutierrez G, Ascensao J. Pulmonary alveolar proteinosis with myeloproliferative syndrome with myelodysplasia: bronchoalveolar lavage reduces white blood cell count. Am J Hematol. 2006;81(8):634–638. doi:https://doi.org/10.1002/ajh.20670.
- Stonebraker JR, Ooi CY, Pace RG, et al. Features of severe liver disease with portal hypertension in patients with cystic fibrosis. Clin Gastroenterol Hepatol. 2016;14(8):1207–1215. e3. doi:https://doi.org/10.1016/j.cgh.2016.03.041.
- Lee JH, Bae SH, Yu JJ, Lee R, Yun YM, Song EY. A case of Shwachman-Diamond syndrome confirmed with genetic analysis in a Korean child. J Korean Med Sci. 2008;23(1):142–145. doi:https://doi.org/10.3346/jkms.2008.23.1.142.
- Abolnezhadian F, SJIJoA I. Identification of a Novel C16orf57 Mutation in Iranian Patient with Clericuzio-type Poikiloderma with Neutropenia (CPN): A Case Report. Asthma Immunol. 2019;:441–446.
- Albrecht T, Poss K, Ayuthaya SIN, Triden L, Schleiss KL, Schleiss MR. Case report of congenital asplenia presenting with Haemophilus influenzae type a (Hia) sepsis: an emerging pediatric infection in Minnesota. BMC Infect Dis. 2019;19(1):947 doi:https://doi.org/10.1186/s12879-019-4572-4.
- Aldave Becerra JC, Cachay Rojas E. A 3-Year-Old Girl with Recurrent Infections and Autoimmunity due to a STAT1 Gain-of-Function Mutation: The Expanding Clinical Presentation of Primary Immunodeficiencies. Front Pediatr. 2017;5:55 doi:https://doi.org/10.3389/fped.2017.00055.
- Elliott I, Patel T, Shah J, Venkatesan P. West-African trypanosomiasis in a returned traveller from Ghana: an unusual cause of progressive neurological decline. Case Reports. 2014;2014(aug14 1):bcr2014204451–bcr2014204451. doi:https://doi.org/10.1136/bcr-2014-204451.
- Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995;58(5):555–561. doi:https://doi.org/10.1136/jnnp.58.5.555.
- Thakur KT, Motta M, Asemota AO, et al. Predictors of outcome in acute encephalitis. Neurology. 2013;81(9):793–800. doi:https://doi.org/10.1212/WNL.0b013e3182a2cc6d.
- Wang W, Zhou Y, Zhong L, et al. RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatr Rheumatol Online J. 2019;17(1):55 doi:https://doi.org/10.1186/s12969-019-0346-1.
- Musabak U, Kartal O, Demirel F, et al. editors. A Fatal Good's Syndrome with Pure Red Cell Aplasia. Annals of allergy asthma & immunology; 2012. New York, NY: Elsevier Science Inc.
- Basnayake B, Wazil A, Nanayakkara N, et al. Atypical hemolytic uremic syndrome: a case report. J Med Case Rep. 2020;14(1):11–15. doi:https://doi.org/10.1186/s13256-019-2334-y.
- Esposito S, Ascolese B, Senatore L, et al. Current Advances in the Understanding and Treatment of Mevalonate Kinase Deficiency. London, England: SAGE Publications Sage; 2014.
- De Klerk J, Duran M, Dorland L, Brouwers H, Bruinvis L, Ketting D. A Patient with Mevalonic Aciduria Presenting with Hepatosplenomegaly, Congenital Anaemia, Thrombocytopenia and Leukocytosis. Studies in Inherited Metabolic Disease: Springer; 1988. p. 233–236.
- Girschick H, Wolf C, Morbach H, Hertzberg C, Lee-Kirsch MA. Severe immune dysregulation with neurological impairment and minor bone changes in a child with spondyloenchondrodysplasia due to two novel mutations in the ACP5 gene. Pediatr Rheumatol Online J. 2015;13(1):37 doi:https://doi.org/10.1186/s12969-015-0035-7.
- Rice G, Patrick T, Parmar R, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;81(4):713–725. doi:https://doi.org/10.1086/521373.
- Van Montfrans JM, Hartman EA, Braun KP, et al. Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations. Rheumatology (Oxford)). 2016;55(5):902–910. doi:https://doi.org/10.1093/rheumatology/kev439.
- Ståhl A-l, Vaziri-Sani F, Heinen S, et al. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood. 2008;111(11):5307–5315. doi:https://doi.org/10.1182/blood-2007-08-106153.
- Hofer J, Janecke AR, Zimmerhackl L, for the German-Austrian HUS Study Group, et al. Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome. CJASN. 2013;8(3):407–415. doi:https://doi.org/10.2215/CJN.01260212.
- Delvaeye M, Noris M, De Vriese A, et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(4):345–357. doi:https://doi.org/10.1056/NEJMoa0810739.
- Kuhns DB, Fink DL, Choi U, et al. Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency. Blood J Am Soc Hematol. 2016;128(17):2135–2143. doi:https://doi.org/10.1182/blood-2016-03-706028.
- Ji Y, Ferracci G, Warley A, et al. beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90 . Proc Natl Acad Sci U S A. 2007;104(21):8839–8844. doi:https://doi.org/10.1073/pnas.0611416104.
- Totani L, Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol. 2010;30(12):2357–2361. doi:https://doi.org/10.1161/ATVBAHA.110.207480.
- Gkaliagkousi E, Corrigall V, Becker S, et al. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J. 2009;30(24):3048–3054. doi:https://doi.org/10.1093/eurheartj/ehp330.
- Dinauer MC. Disorders of Neutrophil Function: An Overview. Neutrophil Methods and Protocols: Springer; 2014. p. 501–515.
- Maugeri N, Rovere-Querini P, Evangelista V, et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood J Am Soc Hematol. 2009;113(21):5254–5265. doi:https://doi.org/10.1182/blood-2008-09-180794.
- Ghalloussi D, Dhenge A, Bergmeier W. New insights into cytoskeletal remodeling during platelet production. J Thromb Haemost. 2019;17(9):1430–1439. doi:https://doi.org/10.1111/jth.14544.
- Di Buduo CA, Alberelli MA, Glembotsky AC, et al. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients. Sci Rep. 2016;6(1):1–11.
- Kahr WH, Lo RW, Li L, et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood J Am Soc Hematol. 2013;122(19):3349–3358. doi:https://doi.org/10.1182/blood-2013-04-499491.
- Luzzatto L. Glucose 6-phosphate dehydrogenase (G6PD) deficiency. 2001.
- Chou JY, Jun HS, Mansfield BC. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J Inherit Metab Dis. 2015;38(3):511–519. doi:https://doi.org/10.1007/s10545-014-9772-x.
- Babior B, Lambeth J, Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys. 2002;397(2):342–344. doi:https://doi.org/10.1006/abbi.2001.2642.
- Cevik O, Adiguzel Z, Baykal AT, Somay G, Sener A. The apoptotic actions of platelets in acute ischemic stroke. Mol Biol Rep. 2013;40(12):6721–6727. doi:https://doi.org/10.1007/s11033-013-2787-9.
- Vlădăreanu A, Popov V, Radeşi S, Onisâi M, Bumbea H. Role of reactive oxygen species in platelet function in normal states and chronic myeloproliferative disorders. Rom J Bioch. 2008;45:221–232.
- Chen S, Su Y, Wang J. ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation. Cell Death Dis. 2013;4(7):e722 doi:https://doi.org/10.1038/cddis.2013.253.
- Arnold DE, Heimall JR. A review of chronic granulomatous disease. Adv Ther. 2017;34(12):2543–2557. doi:https://doi.org/10.1007/s12325-017-0636-2.
- Chou JY, Jun HS, Mansfield BC. Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol. 2010;6(12):676–688. doi:https://doi.org/10.1038/nrendo.2010.189.
- Sinan UY. The Cardiac Related Thrombocytopenia. J Hematol Thrombo. 2015;03(04) doi:https://doi.org/10.4172/2329-8790.1000216.
- Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40(1):195–211. doi:https://doi.org/10.1016/j.pop.2012.11.003.
- von Brühl M-L, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209(4):819–835. doi:https://doi.org/10.1084/jem.20112322.
- Hwa J, Melchinger H, Jain K, Tyagi T. Role of platelet mitochondria: life in a nucleus-free zone. Front Cardiovasc Med. 2019;6:153 doi:https://doi.org/10.3389/fcvm.2019.00153.
- Mitchell O, Feldman DM, Diakow M. Sigal SHJHme, research. The Pathophysiology of Thrombocytopenia in Chronic Liver Disease. 2016;8(39)
- Manali ED, Papadaki G, Konstantonis D, et al. Cardiovascular risk in pulmonary alveolar proteinosis. Expert Rev Respir Med. 2016;10(2):235–240. doi:https://doi.org/10.1586/17476348.2016.1116389.
- Kim KJ, Baek IW, Yoon CH, Kim WU, Cho CS. Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies. Br J Haematol. 2013;161(5):706–714. doi:https://doi.org/10.1111/bjh.12318.
- Rowley JW, Weyrich AS. Ribosomes in platelets protect the messenger. Blood J Am Soc Hematol. 2017;129(17):2343–2345.
- Lesesve JF, Dugué F, Grégoire MJ, Witz F, Dror Y. Shwachman-Diamond syndrome with late-onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report . Eur J Haematol. 2003;71(5):393–395. doi:https://doi.org/10.1034/j.1600-0609.2003.00146.x.
- Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(S1):S34–S45. doi:https://doi.org/10.1002/eji.200737772.
- Behrens K, Alexander WS. Cytokine control of megakaryopoiesis. Growth Factors. 2018;36(3-4):89–103. doi:https://doi.org/10.1080/08977194.2018.1498487.
- Goelz N, Winkler J, Eekels JJ, Rand ML, Speer O, Schmugge M. Cytokine and Chemokine Levels Correlate with Apoptosis Markers in Platelets of Pediatric Patients with Immune Thrombocytopenia. Washington, DC: American Society of Hematology; 2016.
- Kim Y-M, Pae H-O, Park JE, et al. Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;14(1):137–167. doi:https://doi.org/10.1089/ars.2010.3153.
- Singh A, Jindal AK, Joshi V, Anjani G, Rawat A. An updated review on phenocopies of primary immunodeficiency diseases. Genes Dis. 2020;7(1):12–25. doi:https://doi.org/10.1016/j.gendis.2019.09.007.
- Chaudhuri A, Kennedy P. Diagnosis and treatment of viral encephalitis. Postgrad Med J. 2002;78(924):575–583. doi:https://doi.org/10.1136/pmj.78.924.575.
- Kuriakose SM, Singh R, Uzonna JE. Host intracellular signaling events and pro-inflammatory cytokine production in African trypanosomiasis. Front Immunol. 2016;7:181. doi:https://doi.org/10.3389/fimmu.2016.00181.
- Shen Q, Mathew T, Mahadevan K, Wang YE, Wu JZ, Palazzo AF. RanBP2/Nup358 enhances RNAi activity by sumoylating and stabilizing Argonaute 1. BioRxiv. 2019;:555896.
- Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood J Am Soc Hematol. 2001;98(9):2720–2725. doi:https://doi.org/10.1182/blood.v98.9.2720.
- Eren Akarcan S, Ulusoy Severcan E, Edeer Karaca N, et al. Gain-of-function mutations in STAT1: a recently defined cause for chronic mucocutaneous candidiasis disease mimicking combined immunodeficiencies. Case Reports Immunol. 2017;2017:2846928., doi:https://doi.org/10.1155/2017/2846928.
- Baris S, Alroqi F, Kiykim A, et al. Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(7):641–648. doi:https://doi.org/10.1007/s10875-016-0312-3.
- Huang Z, Richmond TD, Muntean AG, Barber DL, Weiss MJ, Crispino J. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. J Clin Invest. 2007;117(12):3890–3899. doi:https://doi.org/10.1172/JCI33010.
- Zhong H, Bussel J, Yazdanbakhsh K. In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia. Br J Haematol. 2015;168(2):274–283. doi:https://doi.org/10.1111/bjh.13126.
- Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). JCM. 2017;6(2):16. doi:https://doi.org/10.3390/jcm6020016.
- Levy‐Mendelovich S, Lev A, Rechavi E, et al. T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing . Clin Exp Immunol. 2017;189(3):310–317. doi:https://doi.org/10.1111/cei.12986.
- Matsumura I, Kanakura Y. Molecular control of megakaryopoiesis and thrombopoiesis. Int J Hematol. 2002;75(5):473–483. doi:https://doi.org/10.1007/BF02982109.
- Dowdell KC, Niemela JE, Price S, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood. 2010;115(25):5164–5169. doi:https://doi.org/10.1182/blood-2010-01-263145.
- Pang L, Weiss MJ, Poncz M. Megakaryocyte biology and related disorders. J Clin Invest. 2005;115(12):3332–3338. doi:https://doi.org/10.1172/JCI26720.
- Feng S, Liang X, Cruz MA, et al. The interaction between factor H and Von Willebrand factor. PLoS One. 2013;8(8):e73715. doi:https://doi.org/10.1371/journal.pone.0073715.
- Licht C, Pluthero FG, Li L, et al. Platelet-associated complement factor H in healthy persons and patients with atypical HUS. Blood J Am Soc Hematol. 2009;114(20):4538–4545. doi:https://doi.org/10.1182/blood-2009-03-205096.
- Davis BK, Wen H, Ting JP-Y. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707–735. doi:https://doi.org/10.1146/annurev-immunol-031210-101405.
- Guo H, Callaway JB, Ting JP. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21(7):677–687. doi:https://doi.org/10.1038/nm.3893.
- Tricarico PM, Marcuzzi A, Piscianz E, Monasta L, Crovella S, Kleiner G. Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis. Int J Mol Sci. 2013;14(12):23274–23288. doi:https://doi.org/10.3390/ijms141223274.
- Munoz MA, Jurczyluk J, Simon A, et al. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency. Front Immunol. 2019;10:1900 doi:https://doi.org/10.3389/fimmu.2019.01900.
- Gardiner EE, Al-Tamimi M, Andrews RK, Berndt MC. Platelet Receptor Shedding. Platelets and Megakaryocytes: Springer; 2012. p. 321–339.
- Agola J, Jim P, Ward H, Basuray S, Wandinger‐Ness A. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet. 2011;80(4):305–318. doi:https://doi.org/10.1111/j.1399-0004.2011.01724.x.
- Drutman SB, Haerynck F, Zhong FL, et al. Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis. Proc Natl Acad Sci U S A. 2019;116(38):19055–19063. doi:https://doi.org/10.1073/pnas.1906184116.
- Utsumi T, Okada S, Izawa K, et al. a Case with spondyloenchondrodysplasia treated with Growth Hormone. Front Endocrinol (Lausanne)). 2017;8:157 doi:https://doi.org/10.3389/fendo.2017.00157.
- Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429–440. doi:https://doi.org/10.1038/nri3850.
- Cunningham A, Beristain-Covarrubias N, Perez-Toledo M, Henderson I, Thomas M, Watson SP. Understanding infection-induced thrombosis: lessons learned from animal models. Front Immunol. 2019;10:2569 doi:https://doi.org/10.3389/fimmu.2019.02569.
- Enoksson SL, Grasset EK, Hägglöf T, et al. The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells. Proc Natl Acad Sci U S A. 2011;108(51):E1399–E407. doi:https://doi.org/10.1073/pnas.1107830108.
- Dostert C, Ludigs K, Guarda G. Innate and adaptive effects of inflammasomes on T cell responses. Curr Opin Immunol. 2013;25(3):359–365. doi:https://doi.org/10.1016/j.coi.2013.02.008.
- Iraqi M, Perdomo J, Yan F, Choi PY, Chong BH. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro. Haematologica. 2015;100(5):623–632. doi:https://doi.org/10.3324/haematol.2014.115634.
- Dunkelberger JR, Song W-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34–50. doi:https://doi.org/10.1038/cr.2009.139.
- Carroll MC. The Role of Complement in B Cell Activation and Tolerance. Advances in Immunology. 74: Elsevier; 1999. p. 61–88.
- Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - Molecular Mechanisms of Activation and Regulation. Front Immunol. 2015;6:262 doi:https://doi.org/10.3389/fimmu.2015.00262.
- Alexander JJ, Hack BK, Cunningham PN, Quigg RJ. A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor. J Biol Chem. 2001;276(34):32129–32135. doi:https://doi.org/10.1074/jbc.M101299200.
- Pouw RB, Gómez Delgado I, López Lera A, et al. High complement factor H-related (FHR)-3 levels are associated with the atypical hemolytic-uremic syndrome-risk allele CFHR3* B. Front Immunol. 2018;9:848. doi:https://doi.org/10.3389/fimmu.2018.00848.
- Ito T, Thachil J, Asakura H, Levy JH, Iba T. Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential . Crit Care. 2019;23(1):280 doi:https://doi.org/10.1186/s13054-019-2552-0.
- Pouw RB, Gomez Delgado I, L, Lera A, et al. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome. Risk Allele CFHR3*B. Front Immunol. 2018;9:848.
- Liu J, Miwa T, Hilliard B, et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med. 2005;201(4):567–577. doi:https://doi.org/10.1084/jem.20040863.
- Ogawara H, Handa H, Morita K, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2003;71(4):283–288. doi:https://doi.org/10.1034/j.1600-0609.2003.00138.x.
- Eriksson O, Mohlin C, Nilsson B, Ekdahl KN. The human platelet as an innate immune cell: interactions between activated platelets and the complement system. Front Immunol. 2019;10:1590. doi:https://doi.org/10.3389/fimmu.2019.01590.
- Tamary H, Alter B. oncology. Current diagnosis of inherited bone marrow failure syndromes. Pediatr Hematol Oncol. 2007;24(2):87–99. doi:https://doi.org/10.1080/08880010601123240.
- Karastaneva A, Lanz S, Wawer A, et al. Immune Thrombocytopenia in Two Unrelated Fanconi Anemia Patients - A Mere Coincidence? Front Pediatr. 2015;3:50 doi:https://doi.org/10.3389/fped.2015.00050.
- Onuma S, Wada T, Araki R, et al. MIRAGE Syndrome Caused by a Novel Missense Variant (p. Ala1479Ser) in the SAMD9 Gene. Hum Genome Var. 2020;7(1):1–4.
- Chen D-H, Below JE, Shimamura A, et al. Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Hum Genet. 2016;98(6):1146–1158. doi:https://doi.org/10.1016/j.ajhg.2016.04.009.
- Painho T, Conceição C, Kjöllerström P, Batalha S. Retinopathy and bone marrow failure revealing Coats plus syndrome. Case Reports. 2018;2018:bcr-2018–224477.
- Shimamura A, Alter B. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24(3):101–122. doi:https://doi.org/10.1016/j.blre.2010.03.002.
- Pawlikowska P, Fouchet P, Vainchenker W, Rosselli F, Naim VJB. Defective endomitosis during megakaryopoiesis leads to thrombocytopenia in Fanca-/- mice. Defective Endomitosis during Megakaryopoiesis Leads to Thrombocytopenia in Fanca−/− Mice. 2014;124(24):3613–3623. doi:https://doi.org/10.1182/blood-2014-01-551457.
- Ahmed IA, Farooqi MS, Vander Lugt MT, et al. Outcomes of hematopoietic cell transplantation in patients with germline SAMD9/SAMD9L mutations. Biol Blood Marrow Transplant. 2019;25(11):2186–2196. doi:https://doi.org/10.1016/j.bbmt.2019.07.007.
- Goudouris ES, Segundo GRS, Poli C. Repercussions of inborn errors of immunity on growth. Jornal de Pediatria. 2019;95:49–S58. doi:https://doi.org/10.1016/j.jpedp.2019.02.008.
- Serwas NK, Hoeger B, Ardy RC, et al. Human DEF6 Deficiency Underlies an Immunodeficiency Syndrome with Systemic Autoimmunity and Aberrant CTLA-4 Homeostasis. Nat Commun. 2019;10(1):1–15.
- Masoom SN, Havaei A. Chediak-Higashi Syndrome Presented with Recurrent Episodes of Diarrhea: A Case Report. Immunol Genetics J. 2018;1(1):44–51.
- Meschede I, Santos T, Izidoro-Toledo T, Gurgel-Gianetti J, Espreafico E. Griscelli syndrome-type 2 in twin siblings: case report and update on RAB27A human mutations and gene structure. Braz J Med Biol Res. 2008;41(10):839–848. doi:https://doi.org/10.1590/s0100-879x2008001000002.
- Viallard J-F, Parrens M, Rieux-Laucat F. Fatal Hypogammaglobulinemia 3 Years after Rituximab in a Patient with Immune Thrombocytopenia: An Underlying Genetic Predisposition? Case Reports in Immunology. 2019;2019:1–6. doi:https://doi.org/10.1155/2019/2543038.
- Mao H, Yang W, Latour S, et al. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease. J Allergy Clin Immunol. 2018;142(2):595–604. e16. doi:https://doi.org/10.1016/j.jaci.2017.10.026.
- Ghosh S, Bienemann K, Boztug K, Borkhardt A. Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects . J Clin Immunol. 2014;34(8):892–899. doi:https://doi.org/10.1007/s10875-014-0110-8.
- Lopez-Herrera G, Tampella G, Pan-Hammarström Q, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986–1001. doi:https://doi.org/10.1016/j.ajhg.2012.04.015.
- Schwab C, Gabrysch A, Olbrich P, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932–1946. doi:https://doi.org/10.1016/j.jaci.2018.02.055.
- Zhang Z, Gothe F, Pennamen P, et al. Human interleukin-2 receptor β mutations associated with defects in immunity and peripheral tolerance. J Exp Med. 2019;216(6):1311–1327. doi:https://doi.org/10.1084/jem.20182304.
- Nalbant EK, Karaosmanoglu N, Kutlu O, Ceylaner S, Eksioglu HM. A rare case of prolidase deficiency with situs inversus totalis, identified by a novel mutation in the PEPD gene. JAAD Case Rep. 2019;5(5):436–438. doi:https://doi.org/10.1016/j.jdcr.2019.03.008.
- Shouval DS, Ebens CL, Murchie R, et al. Large B-cell lymphoma in an adolescent patient with Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016;63(1):e15–e17. doi:https://doi.org/10.1097/MPG.0000000000000532.
- Fabre A, Marchal S, Barlogis V, et al. Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review. J Allergy Clin Immunol Pract. 2019;7(6):1958–1969. e9. doi:https://doi.org/10.1016/j.jaip.2019.02.018.
- Ulinski T, Perrin L, Morris M, et al. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. J Clin Endocrinol Metab. 2006;91(1):192–195. doi:https://doi.org/10.1210/jc.2005-1538.
- Lei L, Muhammad S, Al-Obaidi M, et al. Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ. Pediatr Rheumatol Online J. 2018;16(1):61 doi:https://doi.org/10.1186/s12969-018-0278-1.
- Wei A, Cowie T. Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7 + 2 T > C) affecting the Fas gene . Eur J Haematol. 2007;79(4):363–366. doi:https://doi.org/10.1111/j.1600-0609.2007.00924.x.
- Savic S, Parry D, Carter C, et al. A new case of Fas-associated death domain protein deficiency and update on treatment outcomes. J Allergy Clin Immunol. 2015;136(2):502–505. e4. doi:https://doi.org/10.1016/j.jaci.2015.02.002.
- Wildin R, Smyk-Pearson S, Filipovich A. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002;39(8):537–545. doi:https://doi.org/10.1136/jmg.39.8.537.
- Nurden AT, Nurden P. Congenital platelet disorders and understanding of platelet function. Br J Haematol. 2014;165(2):165–178. doi:https://doi.org/10.1111/bjh.12662.
- Kaplan J, De Domenico I, Ward DM. Chediak-higashi syndrome. Curr Opin Hematol. 2008;15(1):22–29. doi:https://doi.org/10.1097/MOH.0b013e3282f2bcce.
- Meeths M, Chiang SC, Wood SM, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood J Am Soc Hematol. 2011;118(22):5783–5793. doi:https://doi.org/10.1182/blood-2011-07-369090.
- Salzer E, Cagdas D, Hons M, et al. RASGRP1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nat Immunol. 2016;17(12):1352–1360. doi:https://doi.org/10.1038/ni.3575.
- Shadur B, Abuzaitoun O, NaserEddin A, Even-Or E, Zaidman I, Stepensky P. Management of XLP-1 and ITK deficiency: The challenges posed by PID with an unpredictable spectrum of disease manifestations. Clin Immunol. 2019;198:39–45. doi:https://doi.org/10.1016/j.clim.2018.12.016.
- Durrani S, Chicka M, Afroze B. Griscelli syndrome type 2–A case report and clinical approach to silver blonde hair. Egypt J Med Hum Genet. 2016;17(2):229–232. doi:https://doi.org/10.1016/j.ejmhg.2015.08.008.
- Soler-Palacín P, Garcia-Prat M, Martín-Nalda A, et al. LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Front Immunol. 2018;9:2397 doi:https://doi.org/10.3389/fimmu.2018.02397.
- Royce PM, Steinmann B. Prolidase deficiency. Connective Tissue and Its Heritable Disorders. New York: Wiley-Liss; 2002. p. 727–738.
- Fournier B, Tusseau M, Villard M, et al. DEF6 deficiency, a mendelian susceptibility to EBV infection, lymphoma, and autoimmunity. 2020;
- Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M. Autoimmune polyendocrine syndrome type 1: case report and review of literature. Arq Bras Endocrinol Metabol. 2012;56(1):54–66. doi:https://doi.org/10.1590/s0004-27302012000100009.
- Vogel TP, Milner JD, Cooper MA. The ying and yang of STAT3 in human disease. J Clin Immunol. 2015;35(7):615–623. doi:https://doi.org/10.1007/s10875-015-0187-8.
- Milner JD, Vogel TP, Forbes L, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591–599. doi:https://doi.org/10.1182/blood-2014-09-602763.
- Zhou Z, Gushiken FC, Bolgiano D, et al. Signal transducer and activator of transcription 3 (STAT3) regulates collagen-induced platelet aggregation independently of its transcription factor activity. Circulation. 2013;127(4):476–485. doi:https://doi.org/10.1161/CIRCULATIONAHA.112.132126.
- Rao A, Kamani N, Filipovich A, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood. 2007;109(1):383–385. doi:https://doi.org/10.1182/blood-2006-05-025072.
- Bernard JJ, Seweryniak KE, Koniski AD, et al. Foxp3 regulates megakaryopoiesis and platelet function. Arterioscler Thromb Vasc Biol. 2009;29(11):1874–1882. doi:https://doi.org/10.1161/ATVBAHA.109.193805.
- Stritt S, Nurden P, Favier R, et al. Defects in TRPM7 channel function deregulate thrombopoiesis through altered cellular Mg(2+) homeostasis and cytoskeletal architecture. Nat Commun. 2016;7:11097 doi:https://doi.org/10.1038/ncomms11097.
- Tiwari S, Italiano JE, JrBarral DC, et al. A role for Rab27b in NF-E2-dependent pathways of platelet formation. Blood. 2003;102(12):3970–3979. doi:https://doi.org/10.1182/blood-2003-03-0977.
- Tolmachova T, Åbrink M, Futter CE, Authi KS, Seabra MC. Rab27b regulates number and secretion of platelet dense granules. Proc Natl Acad Sci U S A. 2007;104(14):5872–5877. doi:https://doi.org/10.1073/pnas.0609879104.
- Carubbi C, Masselli E, Martini S, et al. Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple. haematologica. 2016;101(7):812–820. doi:https://doi.org/10.3324/haematol.2015.137984.
- Magerus-Chatinet A, Stolzenberg M-C, Lanzarotti N, et al. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation. J Allergy Clin Immunol. 2013;131(2):486–490. doi:https://doi.org/10.1016/j.jaci.2012.06.011.
- Imtiyaz HZ, Rosenberg S, Zhang Y, et al. The Fas-associated death domain protein is required in apoptosis and TLR-induced proliferative responses in B cells. J Immunol. 2006;176(11):6852–6861. doi:https://doi.org/10.4049/jimmunol.176.11.6852.
- Berghe TV, Van Loo G, Saelens X, et al. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD. J Biol Chem. 2004;279(9):7925–7933. doi:https://doi.org/10.1074/jbc.M307807200.
- Okamoto T, Suzuki T, Kusakabe S, et al. Regulation of apoptosis during flavivirus infection. Viruses. 2017;9(9):243. doi:https://doi.org/10.3390/v9090243.
- Kile BT. The role of apoptosis in megakaryocytes and platelets. Br J Haematol. 2014;165(2):217–226. doi:https://doi.org/10.1111/bjh.12757.
- Kayal L, Jayachandran S, Singh K. Idiopathic thrombocytopenic purpura. Contemp Clin Dent. 2014;5(3):410–414. doi:https://doi.org/10.4103/0976-237X.137976.
- Ghanima W, Godeau B, Cines DB, Bussel JB. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood J Am Soc Hematol. 2012;120(5):960–969. doi:https://doi.org/10.1182/blood-2011-12-309153.
- Rodeghiero F. First‐line therapies for immune thrombocytopenic purpura: re‐evaluating the need to treat. European Journal of Haematology. 2008;80:19–26. doi:https://doi.org/10.1111/j.1600-0609.2007.01000.x.
- Chang HK. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus. J Korean Med Sci. 2005;20(5):883–885. doi:https://doi.org/10.3346/jkms.2005.20.5.883.
- Stasi RJBT. Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus. 2011;9(3):262–273. doi:https://doi.org/10.2450/2010.0080-10.
- Patel VL, Mahévas M, Lee SY, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Pharmacy and Therapeutics 2012;119(25):5989–5995. doi:https://doi.org/10.1182/blood-2011-11-393975.
- Khan AM, Mydra H, Nevarez AJP. Therapeutics. Clinical Practice Updates in the Management of Immune Thrombocytopenia. 2017;42(12):756.
- Kiykim A, Ogulur I, Dursun E, et al. Abatacept as a long-term targeted therapy for LRBA deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790–2800. e15. doi:https://doi.org/10.1016/j.jaip.2019.06.011.
- Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood J Am Soc Hematol. 2014;123(18):2759–2767. doi:https://doi.org/10.1182/blood-2013-11-462432.
- Pituch-Noworolska A, Siedlar M, Kowalczyk D, Szaflarska A, Błaut-Szlósarczyk A, Zwonarz K. Thrombocytopenia in common variable immunodeficiency patients - clinical course, management, and effect of immunoglobulins. Cent Eur J Immunol. 2015;40(1):83–90. doi:https://doi.org/10.5114/ceji.2015.50838.
- Au AE, Josefsson EC. Regulation of platelet membrane protein shedding in health and disease. Platelets. 2017;28(4):342–353. doi:https://doi.org/10.1080/09537104.2016.1203401.
- Varady E, Inlay M. BONE MARROW TRANSPLANTATION, A POSSIBLE THERAPY FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA. Exp Hematol. 2019;76:S90. doi:https://doi.org/10.1016/j.exphem.2019.06.450.
- Calvet L, Pereira B, Sapin A-F, Mareynat G, Lautrette A, Souweine B. Contribution to diagnosis and treatment of bone marrow aspirate results in critically ill patients undergoing bone marrow aspiration: a retrospective study of 193 consecutive patients. J Intensive Care. 2017;5(1):67 doi:https://doi.org/10.1186/s40560-017-0263-7.
- Houwerzijl EJ. Studies on megakaryopoiesis in patients with myelodysplasia and idiopathic thrombocytopenic purpura: University Library of Groningen][Host]; 2008.
- Montague SJ, Delierneux C, Lecut C, et al. Soluble GPVI is elevated in injured patients: shedding is mediated by fibrin activation of GPVI. Blood Adv. 2018;2(3):240–251. doi:https://doi.org/10.1182/bloodadvances.2017011171.
- Özden K, Mutlu B, Kahveci G, et al. Pulmonary atresia and ventricular septal defect with MAPCAs associated with right sided endocarditis and paradoxical embolic event. Eur J Echocardiogr. 2007;8(4):292–295. doi:https://doi.org/10.1016/j.euje.2006.03.004.
- Takagi S, Suzuki I, Watanabe S. Risk of thromboembolism in patients with immune thrombocytopenia. J Hematol Thrombo Dis. 2015;3(185)
- Chaturvedi S, Arnold DM, McCrae KR. Splenectomy for immune thrombocytopenia: down but not out. Blood J Am Soc Hematol. 2018;131(11):1172–1182. doi:https://doi.org/10.1182/blood-2017-09-742353.
- Wörmann B. Clinical indications for thrombopoietin and thrombopoietin-receptor agonists. Transfus Med Hemother. 2013;40(5):319–325. doi:https://doi.org/10.1159/000355006.
- Patel SR, Zimring JC. Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens. Transfus Med Rev. 2013;27(4):241–248. doi:https://doi.org/10.1016/j.tmrv.2013.08.002.